Literature DB >> 21684842

The technologies used for developing orally disintegrating tablets: a review.

Bhatu P Badgujar1, Atish S Mundada.   

Abstract

Orally disintegrating tablets (ODTs), also known as fast melts, quick melts, fast disintegrating and orodispersible systems, have the unique property of disintegrating in the mouth in seconds without chewing and the need of water and are thus assumed to improve patient compliance. Conventional methods like direct compression, wet granulation, moulding, spray-drying, freeze-drying and sublimation were used to prepare ODTs. New advanced technologies like Orasolv®, Durasolv®, Wowtab®, Flashtab®, Zydis®, Flashdose®, Oraquick®, Lyoc®, Advatab®, Frosta®, Quick-Disc® and Nanomelt® have been introduced by some pharmaceutical companies for the production of ODTs. The main objective of this review is to give a comprehensive insight into conventional and recent technologies used for the preparation of ODTs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684842     DOI: 10.2478/v10007-011-0020-8

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  23 in total

1.  Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology.

Authors:  Manjeet B Pimparade; Anh Vo; Abhijeet S Maurya; Jungeun Bae; Joseph T Morott; Xin Feng; Dong Wuk Kim; Vijay I Kulkarni; Roshan Tiwari; K Vanaja; Reena Murthy; H N Shivakumar; D Neupane; S R Mishra; S N Murthy; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2017-06-06       Impact factor: 5.571

2.  Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms.

Authors:  Julia T Schiele; Renate Quinzler; Hans-Dieter Klimm; Markus G Pruszydlo; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2012-09-29       Impact factor: 2.953

3.  Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.

Authors:  Manjeet B Pimparade; Joseph T Morott; Jun-Bom Park; Vijay I Kulkarni; Soumyajit Majumdar; S N Murthy; Zhuoyang Lian; Elanor Pinto; Vivian Bi; Thomas Durig; Reena Murthy; H N Shivakumar; K Vanaja; P C Kumar; Michael A Repka
Journal:  Int J Pharm       Date:  2015-04-15       Impact factor: 5.875

4.  Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes.

Authors:  Fan Zeng; Ling Wang; Wenjing Zhang; Kejing Shi; Li Zong
Journal:  AAPS PharmSciTech       Date:  2013-05-07       Impact factor: 3.246

5.  Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.

Authors:  Shohei Nakamura; Tomomi Fukai; Takatoshi Sakamoto
Journal:  AAPS PharmSciTech       Date:  2021-12-23       Impact factor: 3.246

6.  Release kinetics of papaverine hydrochloride from tablets with different excipients.

Authors:  Regina Kasperek; Andrzej Polski; Łukasz Zimmer; Ewa Poleszak
Journal:  Sci Pharm       Date:  2014-05-16

7.  Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method.

Authors:  P Kalyankar; P Panzade; S Lahoti
Journal:  Indian J Pharm Sci       Date:  2015 May-Jun       Impact factor: 0.975

8.  Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.

Authors:  Laurel A Lagenaur; Iwona Swedek; Peter P Lee; Thomas P Parks
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

Review 9.  Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.

Authors:  Felipe L Lopez; Terry B Ernest; Catherine Tuleu; Mine Orlu Gul
Journal:  Expert Opin Drug Deliv       Date:  2015-07-13       Impact factor: 6.648

10.  Design and In Vitro Characterization of Orally Disintegrating Modified Release Tablets of Naproxen Sodium.

Authors:  Amjad Hussain; Maham Misbah; Nasir Abbas; Muhammad Irfan; Muhammad Sohail Arshad; Rahat Shamim; Nadeem Irfan Bukhari; Faisal Mahmood
Journal:  Turk J Pharm Sci       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.